CLINICAL VALUE SCORES FOR TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA WITH TTFIELDS

被引：0
|
作者：
Kelly, J. [1 ]
Proescholdt, C. [2 ]
机构：
[1] Novocure, Portsmouth, NH USA
[2] Novocure, Root, Switzerland
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
10.1093/neuonc/noz126.132
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P08.06
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [31] Quality of life of patients with newly diagnosed glioblastoma during TTFields therapy in routine clinical care: first results of the TIGER study
    Baehr, O.
    Tabatabai, G.
    Fietkau, R.
    Goldbrunner, R.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S44 - S45
  • [32] VOLUMETRIC RESPONSE TO TTFIELDS IN NEWLY DIAGNOSED GBM
    Kerschbaumer, J.
    Freyschlag, C. F.
    Pinggera, D.
    Thome, C.
    NEURO-ONCOLOGY, 2018, 20 : 268 - 268
  • [33] TUMOR TREATING FIELDS (TTFIELDS) THERAPY WITH CHEMORADIATION, FOLLOWED BY MAINTENANCE TTFIELDS THERAPY/TEMOZOLOMIDE (TMZ), IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM). RESULTS OF PHASE II CLINICAL STUDY
    Grossman, Rachel
    NEURO-ONCOLOGY, 2024, 26
  • [34] VOLUMETRIC RESPONSE TO TTFIELDS IN NEWLY DIAGNOSED GBM
    Kerschbaumer, Johannes
    Pinggera, Daniel
    Thome, Claudius
    Freyschlag, Christian
    NEURO-ONCOLOGY, 2018, 20 : 187 - 187
  • [35] VOLUMETRIC RESPONSE TO TTFIELDS IN NEWLY DIAGNOSED GBM
    Freyschlag, Christian
    Kerschbaumer, Johannes
    Pinggera, Daniel
    Thome, Claudius
    NEURO-ONCOLOGY, 2017, 19 : 163 - 163
  • [36] Chemoradiation treatment with or without concurrent tumor-treating fields (TTFields) therapy in newly diagnosed glioblastoma (GBM) patients in China
    Liping Liang
    Lingchao Chen
    Chunxia Ni
    Wenyin Shi
    Zhirui Zhou
    Shu Chen
    Wenjia Zhu
    Jiabing Liu
    Xianxin Qiu
    Wanzun Lin
    Junyan Zhang
    Zhiyong Qin
    Yang Wang
    Chinese Neurosurgical Journal, 11 (1)
  • [37] The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care)
    Baehr, O.
    Tabatabai, G.
    Fietkau, R.
    Goldbrunner, R.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S59 - S59
  • [38] The use of TTFields in Germany in routine clinical care of newly diagnosed GBM patients (TIGER: TTFields in Germany in routine clinical care)
    Baehr, O.
    Tabatabai, G.
    Fietkau, R.
    Goldbrunner, R.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S63 - S64
  • [39] THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE)
    Baehr, O.
    Tabatabai, G.
    Fietkau, R.
    Goldbrunner, R.
    Glas, M. G.
    NEURO-ONCOLOGY, 2019, 21 : 82 - 82
  • [40] THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE)
    Baehr, Oliver
    Tabatabai, Ghazaleh
    Fietkau, Rainer
    Goldbrunner, Roland
    Glas, Martin
    NEURO-ONCOLOGY, 2019, 21 : 20 - 20
12345